Interpret anemia through marrow response, iron availability, globin production and cell maturation, then distinguish hemolysis from failed production.
A low hemoglobin tells you that oxygen-carrying capacity is reduced. It does not tell you whether the marrow lacks ingredients, cannot use them, has lost its precursors, or is trying to replace cells that disappear too quickly. Start with that distinction before attaching a diagnosis to the MCV.
Read cell size beside the marrow response
Confirm anemia against an appropriate age, pregnancy and laboratory reference range. Symptoms reflect severity, speed of onset and cardiopulmonary reserve. Active hemorrhage, syncope, chest pain or circulatory instability require immediate assessment while the cause is investigated. A single hemoglobin can initially underestimate acute blood loss before fluid redistribution.
Use the CBC, reticulocyte count and smear together. In adults, MCV below 80 fL is microcytic, 80 to 100 fL normocytic, and above 100 fL macrocytic. These are starting categories. Early iron deficiency can be normocytic; reticulocytes can raise MCV; simultaneous iron and B12 deficiency can produce a normal average from two abnormal cell populations. RDW describes size variation, not a diagnosis.
Two independent questions organize the anemia workup
Horizontal comparison: cell size
Small: insufficient hemoglobin production. Average: many production and loss disorders. Large: impaired DNA synthesis, membrane effects or young cells.
Vertical comparison: replacement
Inadequate reticulocytes: investigate nutrients, kidney signaling or marrow disease. Appropriate increase: investigate loss or destruction, while allowing for recent treatment.
Use both dimensions. A low MCV does not excuse skipping the reticulocyte count, and a normal MCV does not end the investigation.
A reticulocyte percentage uses the remaining RBCs as its denominator. A value of 2% can be inadequate in marked anemia. The corrected percentage is reticulocyte percentage multiplied by patient hematocrit divided by a reference hematocrit. The reticulocyte production index also adjusts for prolonged maturation of prematurely released cells. For example, 4% with hematocrit 22.5%, reference 45%, and maturation factor 2 gives an index of 1. Absolute reticulocytes and the clinical trajectory are often more practical than a universal numerical cutoff. Production may lag during the first days after bleeding. [21]
Try it here · Checkpoint 1 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 32
Show answer and explanations for case 32
A. 1, indicating an inadequate response for this degree of anemia (Best answer)
The corrected percentage is 2%; dividing by the supplied maturation factor gives an index of 1, an inadequate response to severe anemia.
B. 2, after correction for hematocrit only (Why this does not fit)
This is the corrected reticulocyte percentage; the supplied maturation factor still needs to be applied.
C. 4, using the uncorrected percentage (Why this does not fit)
The raw percentage ignores the reduced RBC denominator and prolonged maturation.
D. 0.5, after applying the maturation factor twice (Why this does not fit)
Correct once for hematocrit and once for maturation: 4 multiplied by 22.5/45, then divided by 2, equals 1.
Takeaway: Correct the denominator before judging whether production matches the anemia.
Iron deficiency limits heme production. Hypochromia, pencil-shaped cells and increasing RDW support the pattern but do not prove it. Low ferritin supports depleted stores; transferrin or TIBC commonly rises while serum iron and transferrin saturation fall. In a patient with anemia, AGA recommends a ferritin cutoff of 45 ng/mL rather than 15 for diagnosing iron deficiency in its gastrointestinal evaluation framework. Ferritin also rises with inflammation, so a reassuring-looking value can conceal deficiency. [1]
Typical untreated iron patterns, interpreted in context
Finding
Iron deficiency
Inflammation
Thalassemia trait
FindingFerritin
Iron deficiencyLow
InflammationNormal or high; mixed deficiency possible
Thalassemia traitUsually normal unless another disorder coexists
FindingTIBC
Iron deficiencyOften high
InflammationOften low or normal
Thalassemia traitUsually normal
FindingRBC count relative to hemoglobin
Iron deficiencyOften reduced
InflammationVariable
Thalassemia traitOften relatively preserved or high
FindingNext useful question
Iron deficiencyWhy is iron being lost or not absorbed?
InflammationIs iron also depleted?
Thalassemia traitWhich globin production defect is present?
During inflammation, cytokine signaling increases hepcidin. Hepcidin causes loss of the iron exporter ferroportin from enterocytes and macrophages, reducing absorption and trapping recycled iron away from developing RBCs. This is iron-restricted erythropoiesis, not proof that the body contains no iron. CKD adds an inappropriately weak erythropoietin signal and other contributors. Evaluate iron status and additional causes before attributing all anemia to kidney disease; iron replacement can be appropriate in CKD or mixed deficiency. [8]
Finding the cause and replacing iron belong in the same care plan. Ask about menstrual and gastrointestinal bleeding, diet, pregnancy, donation and malabsorption. Excess cow's milk can displace iron-rich food in toddlers. [19] Men and postmenopausal women with iron deficiency anemia generally need upper and lower gastrointestinal evaluation. For asymptomatic premenopausal women with iron deficiency anemia, AGA conditionally suggests bidirectional endoscopy over iron alone.
Discuss age, plausible menstrual loss, procedural risk and preferences; menstrual loss does not automatically exclude a gastrointestinal source. Consider celiac serology when clinically plausible. Failure to respond to oral iron prompts review of adherence, tolerance, ongoing loss, absorption and the diagnosis, rather than an immediate declaration of thalassemia. [1]
Small cells can reflect the recipe, not the iron supply
Globin quantity and the developmental switch
Adult HbA contains two alpha and two beta subunits; HbA2 contains two alpha and two delta subunits; fetal HbF contains two alpha and two gamma subunits. The alpha genes HBA1 and HBA2 lie on chromosome 16, giving four copies across the chromosome pair. HBB lies on chromosome 11. A beta-zero allele produces no beta globin; a beta-plus allele produces less. Structural variants such as HbS and HbC change a globin protein rather than simply reducing its quantity. [2]
Alpha gene dosage: read each pair as one chromosome
One inactive copy: -α / αα
Usually a silent carrier with minimal index changes.
Two: -- / αα or -α / -α
Alpha trait, with microcytosis and often normal adult hemoglobin electrophoresis. Cis and trans arrangements carry different reproductive risks.
Three: -- / -α
HbH disease. Excess beta subunits form beta-four tetramers after birth; hemolysis can worsen during infection.
Four: -- / --
Hb Bart syndrome. Gamma-four tetramers bind oxygen too tightly for effective fetal delivery; severe fetal anemia and hydrops can result.
This diagram represents the common deletional forms. Nondeletional variants can produce different severity. Hb Bart syndrome is no longer accurately described as universally fatal: selected pregnancies receive intrauterine transfusions with continued specialist care after birth. [13]
Beta trait often produces striking microcytosis with mild anemia and a relatively high RBC count. Increased HbA2 supports the diagnosis, but iron deficiency can lower HbA2 and recent transfusion can distort hemoglobin fractions. The Mentzer index is a screening aid, especially in children, not a replacement for iron studies and hemoglobin testing. Beta thalassemia intermedia has variable severity and may require transfusion during stress; iron overload can develop even without regular transfusion because absorption increases.
Beta thalassemia major usually becomes clinically evident as HbF declines in infancy. Ineffective erythropoiesis, hemolysis, marrow expansion and extramedullary hematopoiesis account for growth and skeletal changes. Transfusion-dependent disease requires monitoring and treatment of iron overload. HbA is absent in beta-zero/beta-zero disease; other genotypes may retain some HbA. [2]
When iron cannot become useful heme
Lead inhibits aminolevulinic acid dehydratase and ferrochelatase, impairing heme synthesis and shortening RBC survival. Basophilic stippling represents retained ribosomal material and is neither sensitive nor specific for lead. Exposure history, abdominal symptoms and developmental or neurologic findings guide testing. Use a blood lead concentration, with venous confirmation when indicated, rather than urinary ALA or protoporphyrin alone as the diagnostic screen.
Lead neuropathy can include motor weakness such as wrist drop. Severe exposure can cause encephalopathy or seizures, especially in children; lower exposure can still impair development. Anemia is not required for clinically important exposure. Dense metaphyseal bands are a historical radiographic association, not a substitute for blood lead testing. [5][6]
Sideroblastic anemia places iron in mitochondria around an erythroblast nucleus. Ring sideroblasts are identified in iron-stained marrow, not as rings on the routine peripheral smear. Iron stores may be excessive because iron is present but poorly incorporated into heme. Consider inherited synthesis defects, pyridoxine-related mechanisms, alcohol, medications such as isoniazid, copper deficiency and clonal marrow disease. Acquired sideroblastic disorders may be normocytic, macrocytic or dimorphic; the name does not require microcytosis. Treat the specific cause and assess iron burden. [14]
Try it here · Checkpoint 2 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 10
Show answer and explanations for case 10
A. Physiologic decline in erythropoietin after birth (Why this does not fit)
That can contribute to early infant anemia but does not explain severe persistent microcytosis with absent beta production.
B. Depletion of stored iron during infant growth (Why this does not fit)
Iron deficiency is a competing cause of infant microcytosis, but it cannot explain the beta-zero genotype and absent HbA.
C. Declining gamma globin production exposed the lack of beta globin (Best answer)
HbF initially supplies gamma-containing hemoglobin; the developmental switch reveals the beta-production defect.
D. Increased destruction from an acquired RBC autoantibody (Why this does not fit)
Immune hemolysis needs supporting evidence and does not explain the developmental dependence on gamma-containing hemoglobin.
Takeaway: Developmental hemoglobin expression explains the timing of beta thalassemia major.
Large cells: distinguish DNA failure from other causes
B12 and folate deficiency impair DNA synthesis, creating nuclear maturation that lags behind cytoplasmic growth. Macro-ovalocytes and hypersegmented neutrophils support megaloblastic hematopoiesis. Severe deficiency can cause cytopenias and high LDH from ineffective production within marrow, so high LDH alone does not prove peripheral RBC destruction. Alcohol, liver disease, hypothyroidism, reticulocytosis and myelodysplastic neoplasms can also raise MCV.
B12 supports methylmalonyl-CoA metabolism and homocysteine conversion to methionine. Deficiency can increase methylmalonic acid and homocysteine; folate deficiency usually increases homocysteine without increasing methylmalonic acid. Reduced kidney function complicates interpretation of methylmalonic acid. Neuropathy, loss of vibration or position sense, and gait dysfunction favor B12 deficiency, but B12 neurologic disease can occur without anemia or macrocytosis. Do not delay replacement for a prolonged workup when neurologic injury is suspected. [3][4]
Diet without adequate fortified food or supplementation can deplete B12, particularly with vegan intake. Ileal disease such as Crohn's can impair absorption. Fish-tapeworm infection after raw or undercooked fish is another possible cause. [4][25]
The absorption route explains the history: food B12 is released and binds haptocorrin; pancreatic digestion in the duodenum permits binding to intrinsic factor made by gastric parietal cells; the complex is absorbed in the terminal ileum. Autoimmune gastritis, total gastrectomy and complete terminal ileal resection can therefore cause lasting deficiency. NICE recommends lifelong intramuscular replacement for these irreversible causes.
High-dose oral B12 has some passive absorption, so absence of intrinsic factor does not literally abolish every route of absorption. A negative intrinsic-factor antibody result does not exclude autoimmune gastritis. Pernicious anemia names a B12-malabsorption cause, whereas megaloblastic describes cell maturation. Autoimmune gastritis also increases gastric neoplasia risk; new upper gastrointestinal symptoms warrant assessment. [3][4]
Medication review matters: methotrexate antagonizes folate metabolism, while phenytoin can lower folate levels; trimethoprim can contribute to megaloblastic cytopenias, particularly with prolonged exposure or folate deficiency. Do not treat all three as identical therapeutic mechanisms. [20][23]
Folate stores are depleted faster than B12 stores, making inadequate intake, alcohol use and increased demand relevant over months. Assess B12 when treating suspected folate deficiency so improved blood counts do not conceal ongoing neurologic injury. Both deficiencies can coexist in poor intake or malabsorption; increased methylmalonic acid does not exclude an additional folate deficit. Folic acid 400 micrograms daily before conception and during early pregnancy helps prevent neural tube defects. Neural tube closure occurs very early; starting at ten weeks of pregnancy cannot reverse a closure defect already established. [7]
Use the other blood cells and the smear to finish the explanation
Pancytopenia with markedly hypocellular marrow supports aplastic anemia after competing inherited, malignant and toxic causes are assessed. Current treatment of severe acquired disease in adults includes appropriate donor transplantation or horse antithymocyte globulin and ciclosporin with eltrombopag, selected by age, severity and donor availability. Pure red cell aplasia instead produces profound reticulocytopenia with selective erythroid precursor loss and preserved other lineages. Investigate immune disease, thymoma and parvovirus B19; thymoma is a minority association and thymectomy does not reliably cure the anemia. Persistent parvovirus infection in an immunocompromised patient can require PCR testing and IVIG-based treatment. [9][10]
Persistent macrocytosis with additional cytopenias or dysplastic cells needs marrow evaluation after nutritional and other reversible causes are considered. Neither age nor one hyposegmented neutrophil proves myelodysplasia. MDS can progress to acute myeloid leukemia; supportive treatment, disease-directed drugs and transplant are selected according to risk and fitness. Myeloma can produce anemia through marrow involvement, inflammation and kidney injury.
Rouleaux suggests increased plasma proteins but is not diagnostic; monoclonal studies, marrow findings, lytic lesions and attributable organ injury provide the necessary context. Cirrhosis can combine blood loss, nutritional deficiency, hypersplenism and altered RBC membranes. Hepatic synthesis changes affect both procoagulant and anticoagulant proteins, so INR alone does not quantify bleeding risk. [22][11][15]
For suspected hemolysis, seek a coherent pattern: falling hemoglobin, an appropriate reticulocyte response, increased indirect bilirubin and LDH, and reduced haptoglobin. Each has limitations: inflammation can increase haptoglobin, liver failure can lower it, and marrow suppression can prevent reticulocytosis. The direct antiglobulin test detects RBC-bound immunoglobulin or complement and helps investigate immune causes; a positive test alone does not establish active hemolysis.
Spherocytes occur in hereditary spherocytosis and warm immune hemolysis. Warm immune disease can accompany SLE or CLL; adult management commonly starts with corticosteroids while the secondary cause is addressed. [24] Bite cells suggest oxidant injury; schistocytes suggest fragmentation. [12]
Sickle disease can produce painful dactylitis, [26] while abrupt severe anemia with almost no reticulocytes after a viral illness suggests parvovirus-related aplastic crisis. G6PD activity may be falsely reassuring during an acute episode because surviving young cells have greater activity. Acquired PNH warrants flow cytometry when unexplained hemolysis accompanies unusual thrombosis or cytopenias; its name does not confine hemolysis to sleep. A new alloantibody can cause delayed hemolysis after transfusion, which requires blood-bank investigation. [16][12][17][18]
Try it here · Checkpoint 3 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 27
Show answer and explanations for case 27
A. Isolated B12 deficiency (Why this does not fit)
B12 deficiency does not connect the bone lesions and monoclonal protein.
B. Multiple myeloma (Best answer)
The monoclonal protein and attributable bone, renal and hematologic injury support symptomatic plasma cell disease.
C. Iron deficiency alone (Why this does not fit)
That would not explain the monoclonal protein, hypercalcemia and lytic lesions.
D. Benign rouleaux without underlying disease (Why this does not fit)
Rouleaux is nonspecific, but the accompanying organ injury makes reassurance inappropriate.
Takeaway: Interpret rouleaux through the associated protein studies and organ findings.
Each parent passes the cis-deletion chromosome with probability one half; one half multiplied by one half gives one quarter.
B. 0% (Why this does not fit)
Each parent can pass a chromosome missing both alpha genes, so a fetus can inherit two such chromosomes.
C. 50% (Why this does not fit)
One half is the probability of inheriting a deletion chromosome from one parent, not from both independently.
D. 100% (Why this does not fit)
Each parent also has a chromosome containing two functioning alpha genes, so not all fetuses inherit four inactive copies.
Takeaway: Cis alpha deletions in both parents create a one-in-four risk of Hb Bart syndrome; specialist counseling includes modern fetal treatment options.
A. Mixed deficiencies average into a normal MCV (Best answer)
The smear and nutrient results reveal two populations hidden by the mean.
B. Both deficiency assays must be false because MCV is normal (Why this does not fit)
A mean can conceal opposing size abnormalities.
C. Normocytic indices exclude nutritional anemia (Why this does not fit)
Early or mixed nutritional disease may be normocytic.
D. Myelodysplasia is the primary explanation for the two RBC populations (Why this does not fit)
The demonstrated iron and B12 deficiencies directly explain the opposing cell sizes; marrow dysplasia should not be inferred before these deficiencies are addressed.
Takeaway: Do not let an average overrule the actual cell distribution.
Persistent cytopenias, dysplasia and clonal marrow findings support a myeloid neoplasm after a reversible mimic was treated.
B. Copper deficiency (Why this does not fit)
Copper deficiency can cause cytopenias and dysplasia, but the persistent clonal marrow findings support a myelodysplastic neoplasm after reversible causes are excluded.
C. Hereditary spherocytosis (Why this does not fit)
Spherocytosis causes a different RBC phenotype and does not explain clonal neutrophil dysplasia.
D. Transient blood loss (Why this does not fit)
Blood loss does not account for these marrow and neutrophil abnormalities.
Takeaway: MDS needs a supported marrow diagnosis, not an age-based shortcut.
